Lv4
418 积分 2022-07-25 加入
Evolving landscape of thrombotic microangiopathy in kidney transplant recipients in the post–C5 inhibitor era
1个月前
已完结
An ASTCT, CIBMTR, EBMT, and APBMT Consensus Statement Defining Response Criteria for Hematopoietic Cell Transplantation Associated Thrombotic Microangiopathy (TA-TMA) Directed Therapy
2个月前
已完结
Treatment of Early‐Onset Specified and Unspecified Bipolar Disorders: A Systematic Review and Strategies for Identifying and Managing a Thermally Dysregulated Subtype in Children
2个月前
已完结
A piperidinyl indole derivative, potential complement factor B inhibitor, plays a renoprotective role in diabetic nephropathy
3个月前
已完结
Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: final 48-week results from the open-label, randomised, phase 3 APPLY-PNH trial in anti-C5-treated patients and the open-label, single-arm, phase 3 APPOINT-PNH trial in patients previously untreated with complement inhibitors
3个月前
已完结
Oral iptacopan for paroxysmal nocturnal haemoglobinuria—First real‐world experience
3个月前
已完结
Effect of Target‐Mediated Disposition on Iptacopan Clinical Pharmacokinetics in Participants with Normal or Impaired Hepatic Function
4个月前
已完结
Eculizumab for transplant‐associated thrombotic microangiopathy in adult allogeneic stem cell transplant recipients
5个月前
已完结
Thrombotic microangiopathy caused by severe graft dysfunction after living donor liver transplantation: report of a case
5个月前
已完结
The outcomes of thrombotic microangiopathy after liver transplantation: A nationwide survey in Japan
5个月前
已完结
皖公网安备34019202002308
